Fukui Hirokazu, Xu Xin, Miwa Hiroto
Division of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa, Nishinomiya, Japan.
Department of Digestive Diseases, Tianjin Medical University General Hospital, Tianjin, China.
J Neurogastroenterol Motil. 2018 Jul 30;24(3):367-386. doi: 10.5056/jnm18071.
Gut microbiota exert a pivotal influence on various functions including gastrointestinal (GI) motility, metabolism, nutrition, immunity, and the neuroendocrine system in the host. These effects are mediated by not only short-chain fatty acids produced by microbiota but also gut hormones and inflammatory signaling by enteroendocrine and immune cells under the influence of the microbiota. GI motility is orchestrated by the enteric nervous system and hormonal networks, and disturbance of GI motility plays an important role in the pathophysiology of functional gastrointestinal disorders (FGIDs). In this context, microbiota-associated mediators are considered to act on specific receptors, thus affecting the enteric nervous system and, subsequently, GI motility. Thus, the pathophysiology of FGIDs is based on alterations of the gut microbiota/gut hormone axis, which have crucial effects on GI motility.
肠道微生物群对宿主的多种功能发挥着关键影响,包括胃肠(GI)蠕动、新陈代谢、营养、免疫和神经内分泌系统。这些作用不仅由微生物群产生的短链脂肪酸介导,还由肠道激素以及在微生物群影响下肠内分泌和免疫细胞产生的炎症信号介导。胃肠蠕动由肠神经系统和激素网络协调,胃肠蠕动紊乱在功能性胃肠疾病(FGIDs)的病理生理学中起重要作用。在这种情况下,微生物群相关介质被认为作用于特定受体,从而影响肠神经系统,进而影响胃肠蠕动。因此,FGIDs的病理生理学基于肠道微生物群/肠道激素轴的改变,这对胃肠蠕动有至关重要的影响。